clear cell renal cell carcinoma
Survival Benefit Seen With Adjuvant Therapy in Patients With ccRCC
Adjuvant pembrolizumab (Keytruda, Merck) significantly improved overall survival in patients with clear cell renal ...
FEBRUARY 15, 2024

Load more